@article{33196,
  keywords = {Elimination, Sleeping sickness, Financial burden, African trypanosomiasis},
  author = {Sutherland S and Tediosi F},
  title = {Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis in sub-Saharan Africa},
  abstract = {<p>Programme to eliminate neglected tropical diseases (NTDs) have gained global recognition, and may allow for improvements to universal health coverage and poverty alleviation. It is hoped that elimination of human African trypanosomiasis (HAT) Trypanosoma brucei gambiense (Tbg) would assist in this goal, but the financial costs are still unknown. The objective of this analysis was to forecast the financial burden of direct costs of HAT Tbg to funders and society.</p>
},
  year = {2019},
  journal = {BMJ Global Health},
  volume = {4},
  publisher = {BMJ},
  url = {https://gh.bmj.com/content/4/2/e001173},
  doi = {10.1136/bmjgh-2018-001173},
  language = {eng},
}